Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

Nature Medicine

Volumn 2, Issue 5, 1996, Pages 529-533

  Hammes, Hans Peter ^a   Brownlee, Michael ^b   Jonzcyk, Alfred ^c   Sutter, Arne ^c   Preissner, Klaus T ^d  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MERCK KGAA   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; INTEGRIN; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLINDNESS; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DISEASE; RETINA NEOVASCULARIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; INTEGRINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; RECEPTORS, VITRONECTIN; RETINAL NEOVASCULARIZATION;

EID: 0029925079     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0596-529     Document Type: Article

References (34)

1. Prost, M. Experimental studies on the pathogensis of retinopathy of prematurity. Br. J. Ophthalmol. 72, 363-367 (1988).
2. Thylefors, B., Negrel, A.D., Pararajasegaram, R. & Dadzie, K.Y. Global data on blindness. Bull. World. Health. Organ. 73, 115-121 (1995).
3. Moss, S.E., Klein, R. & Klein, B.E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101, 1061-1070 (1994).
4. Brown, G.C., Brown, R.H. & Brown, M.M. Peripheral proliferative retinopathies. Int. Ophthalmol. 11, 41-50 (1987).
5. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of DRS findings. Ophthalmology 88, 583-600 (1981).
6. Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747 (1995).
7. Peter, J. et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Invest. 72, 638-645 (1995).
8. Bischoff, J. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol. 5, 69-74 (1995).
9. Bacharach, E., Itin, A. & Keshet, E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA 89, 10686-10690 (1992).
10. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P. & Smith, L.E.H. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905-909 (1995).
11. Schultz, G.S. & Grant, M.B. Neovascular growth factors. Eye 5, 170-180 (1991).
12. Pfeiffer, A. & Schatz, H. Diabetic microvascular complications and growth factors. Exp. Clin. Endocrinol. Diabetes 103, 7-14 (1995).
13. Berka, J.L. et al. Renin-containing Mueller cells of the retina display endocrine features. Invest. Ophthalmol. Vis. Sci. 36, 1450-1458 (1995).
14. Robbins, S.G. et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest. Ophthalmol. Vis. Sci. 35, 3649-3663 (1994).
15. Spranger, J., Meyer-Schwickerath, R., Klein, M., Schatz, H. & Pfeiffer, A. TNF-α level in the vitreous body: Increase in neovascular eye diseases and proliferative diabetic retinopathy. Med. Klin. 90, 134-137 (1995).
16. Leavesley, D.I., Ferguson, G.D., Wayner, E.A. & Cheresh, D.A. Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J. Cell Biol. 117, 1101-1107 (1992).
17. Felding-Habermann, B. & Cheresh, D.A. Vitronectin and its receptors. Curr. Opin. Cell Biol. 5, 864-868 (1993).
18. Brooks, P.C., Clark, R.A.F. & Cheresh, D.A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569-571 (1994).
19. Casaroli Marano, R.P. & Vilaro, S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 35, 2791-2903 (1994).
20. Casaroli Marano, R.P., Preissner, K.T. & Vilaro, S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp. Eye Res. 60, 5-17 (1995).
21. Brooks, P.C. et al. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164 (1994).
22. v integrins. Science 270, 1500-1502 (1995).
23. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W. & Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579 (1994).
24. Smith, L.E.H. et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Invest. Ophthalmol. Vis. Sci. 35, 101-111 (1994).
25. Aumailley, M. et al. Arg-Gly-Asp constrained within cyclic pentapeptides: Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 291, 50-54 (1991).
26. Sasisekharan, R., Moses, M.A., Nugent, M.A., Cooney, C.L. & Langer, R. Hepa rinase inhibits neovascularization. Proc. Natl. Acad. Sci. USA 91, 1524-1528 (1994).
27. Iruela-Arispe, M.L., Bornstein, P. & Sage, H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA 88, 5026-5030 (1991).
28. Dameron, K.M., Volpert, O.V., Tainsky, M.A. & Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584 (1994).
29. Moses, M.A., Sudhalter, J. & Langer, R. Identification of an inhibitor of neovascularization from cartilage. Science 248, 1408-1410 (1990).
30. Johnson, M.D. et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160, 194-202 (1994).
31. O'Reilly, M.S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
32. Aiello, L.P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480-1487 (1994).
33. Jonczyk, A. et al. Zyklische Adhäsionsinhibitoren. EP 0 632 053 (1993).
34. Preissner, K.T., Anders, E., Grulich-Henn, J. & Müller-Berghaus, G. Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. Blood 71, 1581-1589 (1988).